Physician profile
Bisrat Nigussie
NPI 1275060949
$4,173.93
in general payments reported to CMS, 2019-2025
25 companies · $692 in 2025
The $692 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.26 · 2021: $39.22 · 2022: $590 · 2023: $1,080 · 2024: $1,753 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,388.08 |
| Education | $136.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $575.08 | 2022-2024 | Resonate El Icd Vr, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $475.02 | 2021-2024 | Lifevest |
| Scpharmaceuticals INC. | $329.95 | 2024 | |
| Abbott Laboratories | $294.82 | 2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $293.05 | 2022-2024 | Amvuttra, Onpattro |
| Shockwave Medical, INC | $284.26 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $247.40 | 2022-2023 | Camzyos |
| Irhythm Technologies, INC. | $234.25 | 2024 | Zio Monitor, Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $228.92 | 2020-2024 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $182.17 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $148.76 | 2022-2023 | Verquvo |
| Heartflow, INC. | $139.80 | 2025 | |
| Kestra Medical Technology Services, INC. | $130.12 | 2024 | Assure Wcd |
| Amgen INC. | $127.77 | 2023-2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $83.23 | 2023-2024 | Inpefa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $64.53 | 2025 | Symphony Catheter |
| Lantheus Medical Imaging, INC. | $56.65 | 2024-2025 | |
| Baxter Healthcare | $49.17 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $39.31 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $36.36 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.38 | 2025 | Jardiance |
| Biotronik INC. | $32.86 | 2024 | Acticor 7 Vr-T Dx |
| Novartis Pharmaceuticals Corporation | $29.80 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $29.71 | 2024 | Uptravi, Opsumit |
| Atricure, INC. | $26.56 | 2025 | Atriclip Laa Exclusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bisrat Nigussie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.